[Effect of Cynarin on hyperlipidemia with special reference to type II (hypercholesterinemia)].
D000368:Aged; D001835:Body Weight; D050260:Carbohydrate Metabolism; D002756:Cholagogues and Choleretics / Q000627:therapeutic use*; D002934:Cinnamates / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy* / Q000378:metabolism; D006973:Hypertension / Q000378:metabolism; D050356:Lipid Metabolism; D008297:Male; D008875:Middle Aged
D002756:Cholagogues and Choleretics; D002934:Cinnamates; D003509:Cyclohexanecarboxylic Acids
Uber den Einflubb von Cynarin auf Hyperlipidämien unter besonderer Berücksichtigung des Typs II (Hpercholesterinämie.